Ghassem Attarzadeh Yazdi
Assistant Professor PhD, Physiology Hormozgan University of Medical Sciences Phone: + 989126843010 Email: [email protected] -----------------------------------------------------------------------------------------------------------------
Education:
Ph.D. of Neuroscience: Department of Neuroscience, University of Edinburgh, 2002-06. M.Sc. of Human Physiology: Tarbiat Modarres University-Tehran-Iran, 1992-95. B.Sc. of Biology: Ferdowsi University-Mashad-Iran, 1984-89. Employment:
1995-2002: Hormozgan University of Medical Sciences, Department of Physiology, lecturer 2010-now: Hormozgan University of Medical Sciences, Physiology Department, Assistant Presentations: 1: The role of spinal and supraspinal alpha-2 adrenoceptors on pain (tonic and chronic) by
using dexmedetomidine, First FAONS congress and first IBRO Regional congress (1996-
2: Assessing the nociceptive effects of dexmedetomidine a novel alpha- 2 adrenoceptor agonist.
12th Iranian Physiology & Pharmacology Congress, Tehran, 6-9 Nov 1995.
3: The central effect of Dexmedetomidine, a novel alpha-2 adrenoceptor agonist on acute pain.
The 4th National congress on Biology, Gorgan, Iran, 1995.
4: The alpha-2 adrenoceptors Mechanism in nociception, XXXIII International congress of
physiology science, IUPS (1997- St. Petersburg, Russia).
5: Mechanism of alpha-2 adrenoceptors in nociception. Lecture at first neuroscience congress 6: The effect of Clonidine and Dexmedetomidine on ocular pressure. Lecture at 13th Iranian
Physiology & Pharmacology Congress, Tehran, 1997.
7: The effect of Clonidine and Dexmedetomidine on ocular pressure, FAONS, FAOPS congress 8: The effect of locus ceruleus alpha-2 adrenoceptors on pain, FENS 2000 congress in UK (24 - 9: No effect of dexamethasone on dex-ras1 mRNA Human Embryonic Kidney (HEK 293) cells, 10: Investigation of Dex-ras1 and SGK-1 expression in Human Embryonic Kidney (HEK 293)
cells. Lecture at 12th Iranian Research Conference in Europe, 2004.
11: Ser/Thr protein phosphatases constitutively associated with large-Conductance calcium-
activated potassium (BK) channels, Bioscience 2005-Glasgow, UK.
12: The association of Ser/Thr protein phosphatases with with large-Conductance calcium-
activated potassium (BK) channels. Lecture at 13th Iranian Research Conference in Europe,
13: Constitutive association of protein phosphatase 2A with large-conductance calcium-
activated potassium (BK) channels, XXXV IUPS 2005, USA.
14: Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual
potential, E u r o p e a n P a e d i a t r i c O p h t h a l m o l o g i c a l S o c i e t y , 2 0 0 5 .
15: Semliki Forest virus (Alphavirus) interactions with mosquito innate immunity. Ento'07-RES
Annual Meeting, 16th-18th July 2007, Edinburgh, UK.
16: Semliki Forest Virus Interactions with RNAi in Mosquito Cells. RNAi World Congress, 30 17: Semliki Forest virus (Alphavirus) interactions with mosquito innate Immunity, 4th
European Viral Zoonoses Meeting 2007 (St. Andrews, UK).
18: Molecular mechanism of glucocorticoid action on ion channels. Lecture at 18th Iranian
congress of physiology and pharmacology, Mashhad, Iran, 2007.
19: Investigation of SGK-1 and Dexras1 expression in Human Embryonic Kidney (HEK 293):
Lecture at EHRLICH II –2nd World Conference, Nürnberg, Germany, October 3-5, 2008.
20: Non-RNA interference-mediated suppression of Semliki Forest Virus Infection of Mosquito
Cells by Double-stranded RNA, Controlling Emerging Infectious Diseases in the 21st Century,
21: Double-stranded RNA (dsRNA) induces a non-sequence-specific antiviral state in mosquito
cells, SGM, Edinburgh, 29 March - 1 April 2010.
22: Non-sequence-specific antiviral state in mosquito cells by double-stranded RNA (dsRNA),
RNAi and miRNA Eurtope, Dublin, Ireland, 14-15 Sep 2010,
23: Molecular mechanism of glucocorticoid on ACTH, First-IBRO Middle East Neuroscience 24: Molecular mechanism of glucocorticoid action on ion channel, 1st neuroscience congress, Gorgan
University of Medical Sciences, Iran, 16-17 Feb, 2011.
Publications: 1: Peripheral and central effects of Dexametomidine, a specific alpha-2 adrenergic agonist, on
phasic and tonic pain. Physiology and Pharmacology Journal, Iran Journal, 1376.
2: Molecular mechanism of alpha-2 adrenoceptors on pain. Hormozgan Medical Journal, Iran, 3: La Crosse Bunyavirus Nonstructural Protein NSs Serves to Suppress the Type I Interferon
system of Mammalian Hosts. Journal of Virology, DOI:10.1128/JVI. 01933-06, 2007.
4: Dex-Ras1 and serum- and glucocorticoid-inducible protein kinase1: Regulation of expression
by Dexamethasone in HEK 293 cells. Neurochemical Research, DOI: 10.1007/s11064-007-
5:Insect Mol Biol, Dec; 6: PKR acts early in infection to suppress Semliki Forest virus production and strongly
enhances the type-I interferon response. Journal of General Virology, 10.1099/vir. 0.007336-0,
7: Cell to cell spread of the RNAi response suppresses Semliki Forest virus infection of
mosquito cells. Journal of Virology, 10.1128/JVI.02440-08, 2009.
8: Advances in dissecting mosquito innate immune responses to arbovirus infection. Journal of 9: Antiviral RNA interference responses induced by Semliki Forest virus infection of mosquito cells:
Characterization, origin and frequency-dependent functions of vi2010 Dec
RNA extraction Cell culture Cloning and subcloning RT-PCR Restriction digestion of DNA Alkaline lysis: Plasmid DNA purification Transfection reporter gene assays Virology techniques Transient transfection Determination of protein concentration Immunoprecipitation Western Blot Labelling the probe (Radioactive) Northern Blot Immunostaining siRNA transfection methods Plaque assay FACS analysis
Workshops and Courses:
Radioactive course, Project Management for Researchers Presentation Skills Supervising Postgraduate Research Medical Journalism
Current Industrial ReportsU.S. Department of CommerceEconomics and Statistics AdministrationBureau of the CensusPharmaceuticals, Except Biologicals - 1997Information about the scope of the survey, methodology, explanation of terms,and historical notes for this survey may be found in the 1996 ManufacturingProfiles issued July 1998. Obtaining reports: Current data are released electronically on I
First Product Approved for Premenstrual Dysphoric Disorder (PMDD) Brand Name Sarafem™ Premenstrual Dysphoric Disorder (PMDD), a more severe form ofpremenstrual syndrome (PMS), affects approximately 3-5% ofmenstruating women in the U.S. Symptoms include a range of Generic Name fluoxetine hydrochloride emotional changes and physical complaints that occur one to twoweeks before a